Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1980 2
1981 3
1982 4
1983 1
1984 4
1985 3
1986 4
1987 1
1988 2
1989 2
1990 4
1992 6
1994 4
1996 4
1997 3
1998 2
1999 3
2000 3
2001 3
2002 2
2003 2
2004 3
2005 2
2006 4
2007 4
2008 7
2009 5
2010 3
2011 16
2012 14
2013 8
2014 6
2015 11
2016 15
2017 20
2018 23
2019 19
2020 22
2021 31
2022 44
2023 46
2024 48
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

371 results

Results by year

Filters applied: . Clear all
Page 1
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Gounder M, et al. Among authors: bui nq. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. N Engl J Med. 2023. PMID: 36884323 Free PMC article. Clinical Trial.
Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy.
Subramanian A, Nemat-Gorgani N, Ellis-Caleo TJ, van IJzendoorn DGP, Sears TJ, Somani A, Luca BA, Zhou MY, Bradic M, Torres IA, Oladipo E, New C, Kenney DE, Avedian RS, Steffner RJ, Binkley MS, Mohler DG, Tap WD, D'Angelo SP, van de Rijn M, Ganjoo KN, Bui NQ, Charville GW, Newman AM, Moding EJ. Subramanian A, et al. Among authors: bui nq. Nat Cancer. 2024 Apr;5(4):642-658. doi: 10.1038/s43018-024-00743-y. Epub 2024 Mar 1. Nat Cancer. 2024. PMID: 38429415 Free PMC article.
Editorial.
Bui N. Bui N. Curr Probl Cancer. 2019 Aug;43(4):249. doi: 10.1016/j.currproblcancer.2019.07.002. Curr Probl Cancer. 2019. PMID: 31511143 No abstract available.
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
Ingham M, Allred JB, Chen L, Das B, Kochupurakkal B, Gano K, George S, Attia S, Burgess MA, Seetharam M, Boikos SA, Bui N, Chen JL, Close JL, Cote GM, Thaker PH, Ivy SP, Bose S, D'Andrea A, Marino-Enriquez A, Shapiro GI, Schwartz GK. Ingham M, et al. Among authors: bui n. J Clin Oncol. 2023 Sep 1;41(25):4154-4163. doi: 10.1200/JCO.23.00402. Epub 2023 Jul 19. J Clin Oncol. 2023. PMID: 37467452 Free PMC article.
Letter to the Editor.
Ho J, Lim L, Bruzze L, Marshall A, Christie A, Kaur S, Bui N, Burke G, Youde S, Ramjan K, Wanaguru A, Nyunt O, Verge C, Hameed S. Ho J, et al. Among authors: bui n. J Paediatr Child Health. 2024 Dec;60(12):893-895. doi: 10.1111/jpc.16700. Epub 2024 Oct 17. J Paediatr Child Health. 2024. PMID: 39420504 No abstract available.
Molecular insights into desmoid tumors.
Bui N, Kummar S. Bui N, et al. Oncotarget. 2017 Sep 28;8(53):90608-90609. doi: 10.18632/oncotarget.21293. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207578 Free PMC article. No abstract available.
Computational tools supporting known miRNA identification.
Do VQ, Hoang-Thi C, Pham TT, Bui NL, Kim DT, Chu DT. Do VQ, et al. Among authors: bui nl. Prog Mol Biol Transl Sci. 2024;203:225-242. doi: 10.1016/bs.pmbts.2023.12.018. Epub 2024 Jan 30. Prog Mol Biol Transl Sci. 2024. PMID: 38360000 Review.
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site.
Banach BB, Pletnev S, Olia AS, Xu K, Zhang B, Rawi R, Bylund T, Doria-Rose NA, Nguyen TD, Fahad AS, Lee M, Lin BC, Liu T, Louder MK, Madan B, McKee K, O'Dell S, Sastry M, Schön A, Bui N, Shen CH, Wolfe JR, Chuang GY, Mascola JR, Kwong PD, DeKosky BJ. Banach BB, et al. Among authors: bui n. Nat Commun. 2023 Nov 21;14(1):7593. doi: 10.1038/s41467-023-42098-5. Nat Commun. 2023. PMID: 37989731 Free PMC article.
371 results